Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.243NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
R.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.216NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.471NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.420NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.518NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.551NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.207NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.604NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.619NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.316NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.436NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.558NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.518NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.368NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.404NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.306NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.328NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.533NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.389NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.549NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.50 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.266NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.253NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.305NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.241NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.326NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.255NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.303NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.173NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used